Optimizing cell therapy with spatial biology

Engineering cells with AI-powered models

Compressing years of work into a single experiment

Testing thousands of potential therapies in one model
x
Measuring hundreds of phenotypes at the single cell level
Computer Vision
Generative AI
Pooled Screening

Leveraging advances in AI/ML, computer vision, and pooled screening

Waypoint achieves deep phenotyping across thousands of cell therapy designs. By using spatial biology profiling to rank order designs, we discover and optimize superior cell therapy designs for development.
Computer Vision
Generative AI
Pooled Screening
Spatial imagery

Developing better treatments faster

Addressing unmet need for patients with solid tumors and beyond.

Supported by